Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Innovative Drugs	77.92M	Log In	Log In
Innovative Drugs Growth	5.82%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
China	77.92M	Log In	Log In
China Growth	5.82%	Log In	Log In